Abstract SPG8 is a rare autosomal dominant hereditary spastic paraplegia (AD-HSP), with only six SPG8 families described so far. Our purpose was to screen for KIAA0196 (SPG8) mutations in AD-HSP patients and to investigate their phenotype. Extensive family investigation was performed after positive KIAA0196 mutation analysis, which was part of an on-going mutation screening effort in AD-HSP patients. A novel pathogenic KIAA0196 mutation p.(Gly696Ala) was identified in two AD-HSP patients, who subsequently were shown to belong to a single large Dutch pedigree with more than 10 affected family members. The phenotype consisted of a pure HSP with ages at onset between 20 and 60 years, distally reduced vibration sense in the legs in all, and urinary urgency in seven out of 10 patients. Frequent features were exercise-or emotioninduced increase of spasticity and gait problems and chronic nonspecific lower back and joint pains. We have identified a fourth pathogenic KIAA0196 mutation in a Dutch HSP-family, the seventh family worldwide, with a less severe clinical course than described before.
Introduction
Hereditary spastic paraplegias (HSPs) constitute a genetically and clinically heterogeneous group of neurodegenerative disorders of which the main clinical feature is progressive lower limb spasticity due to pyramidal tract dysfunction, either with ('complicated') or without ('pure') additional signs and symptoms. Autosomal dominant HSPs (AD-HSPs) are the most common genotypes, in most instances associated with a pure HSP. Currently, among the 55 known HSPs named SPG1-55, at least 10 known genes and another seven loci have been associated with AD-HSP. Autosomal-dominant spastic paraplegia type 4, caused by mutations in the SPAST gene, is by far the most frequent form, accounting for almost 50 % of AD-HSP cases [1] . A rare AD-HSP is SPG8, caused by a mutation in the KIAA0196 gene on chromosome 8. This gene encodes the protein strumpellin, a subunit of the WASH complex (Wiskott-Aldrich syndrome protein and SCAR homolog), implicated in endosomal fission [2] . Recently, strumpellin was also reported to interact with valosin-containing protein (VCP), a ubiquitously expressed member of the AAA-ATPase family with a wide variety of cellular functions [3] . As we have very recently identified a VCP mutation in a family with a more complicated HSP, a link between VCP and strumpellin mediated pathways is suggested [4] .
Thus far, there is only one report of mutations in KIAA0196 causing HSP [5] . Here, we describe the clinical characteristics of a large Dutch kindred with AD-HSP caused by a novel mutation in the KIAA0196 gene.
Methods

Patients
The Radboud University Nijmegen Medical Centre serves as a tertiary referral centre for HSP patients. There is an ongoing effort to screen HSP patients for selected SPG mutations. From this database, we selected twenty-one index patients with possible or definite autosomal dominantly inherited HSP, in whom mutations in ATL1 (SPG3A), SPAST (SPG4), REEP1 (SPG31), and in some also NIPA1 (SPG6) and KIF5A (SPG10) had already been excluded. KIAA0196 analysis was performed after the patients gave their written consent (in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments). Index patients who harboured a mutation underwent additional clinical examinations, as did their affected relatives in whom the same pathogenic mutation was subsequently confirmed. This study has been carried out in the Netherlands in accordance with the rules set by the national research ethics committees on the review of studies.
Genetic analysis
For all patients, mutation analysis of the KIAA0196 gene was performed by sequencing the coding region and the flanking splice sites by Sanger sequencing using standard techniques.
The mutation nomenclature was based on the reference sequences NM_014846.3 and on HGVS (version 2) guidelines (www.HGVS.org). Estimation of pathogenicity of the point mutation was done in silico using the prediction programs SIFT (Sorting Intolerance from Tolerance; http://sift.jcvi.org), Align GVGD (http://agvgd.iarc.fr/), POLYPHEN (Polymorphism Phenotyping; http://genetics. bwh.harvard.edu/pph/) [6, 7] , and the HOPE project [8] . The estimation of the probability of the mutation being pathogenic from the co-segregation study was done using the simplified method for segregation analysis (SISA) [9] . In this family, the following parameters were used: Carrier_ set_1 = 10 (affected carriers) and the number of informative meiosis is nine.
Results
Genetic analysis of KIAA0196 yielded a novel missense mutation in exon 17: c.2087G [C; p.(Gly696Ala) in two index patients out of 21 selected individuals with AD-HSP. Extensive genealogical analysis revealed that the two apparently unrelated individuals shared a common distant ancestor (Fig. 1 ). Subsequently, the mutation then was found in another eight affected relatives. Additional testing in an unaffected 85 year old relative (VI; 7 in Fig. 1 ) did not reveal the mutation. The chance that this relative would still develop spastic paraplegia at such an old age is highly unlikely, given the known ages at onset of AD-HSP's (childhood until 60 s) caused by SPAST mutations for example [1] . Thus, the mutation co-segregates fully with the spastic paraplegia. No mutation analysis was performed in asymptomatic members of the younger generation VIII (all aged under 40) because of the possibility that they may be presymptomatic mutation carriers.
Although no 3D-structure of strumpellin is available, glycine is the smallest and most flexible amino acid, while its substituted alanine is larger and less flexible, suggesting that the confirmation of strumpellin will be compromised by the mutation. Also, the glycine (Gly) at position 696 in the strumpellin protein remains highly conserved during evolution, since no other amino acid is present at this position in all known strumpellin proteins of animal species, including Drosophila melanogaster (fruit fly) and Caenorhabditis elegans (nematode) (Fig. 2) .
Thus the pathogenicity of this mutation is supported by the fact that this variant (a) is a change of an evolutionary conserved amino acid, (b) was not reported in approximately 13,000 control chromosomes (Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA (URL: http://evs.gs.washington.edu/EVS/) [June 2012 accessed]), and (c) co-segregates with a pure form of HSP (10 affected relatives) yielding a probability of the mutation to be pathogenic of 0.998 by the simplified method for segregation analysis (SISA) [9] .
Clinically, a rather pure spastic paraplegia was found in all 10 patients (six women) with a mean age at onset of 38.7 ± 11.7 years SD (range 21-57 years). The clinical characteristics after a disease duration of 8-33 years (mean: 20.6 years) are presented in Table 1 . The core phenotype consists of pyramidal symptoms and signs limited to the legs, with hyperreflexia and a spastic gait. Additionally, there was some hyperreflexia in the arms in eight patients, mild upper extremity ataxia in three (without cerebellar abnormalities of the extra-ocular eye movements or lower extremities), and very mild dysphagia in another four patients. Other notable additional symptoms and signs were: impaired vibration sense in the lower legs in all 10 patients without electrophysiological signs of peripheral neuropathy, urinary urge in seven patients and fecal urgency in one other patient. Five patients suffered from chronic nonspecific lower back pain and three others reported frequent nonrheumatic joint pains.
A walking aid (either a cane, walker or wheelchair for longer distances) was needed after two to three decades. At the time of examination, three patients, with disease durations between 24 and 33 years, used a wheelchair. Seven out of 10 patients complained about an increase of spasticity and gait problems induced by either exercise or emotions, sometimes accompanied by leg tremors.
Discussion
We here report the clinical details of a large AD-HSP family with a novel Gly696Ala missense mutation in KIAA0196 (SPG8). The p.Gly696Ala mutation in strumpellin is a change of an evolutionary-conserved amino acid, was not reported in approximately 13,000 control chromosomes (http://evs.gs.washington.edu/EVS/) and segregates with HSP in this large family (SISA score: 0.998), supporting the pathogenicity of this KIAA0196 variant.
The phenotype of a pure HSP in our patients was similar to that in previous reports of SPG8/KIAA0196, including the age at onset range between the 20 and 60 s, with a preference for the third and fourth decade [5, [10] [11] [12] . The more severe clinical course with early wheelchair use as described before could not be confirmed in our family, as only three patients used a wheelchair after a mean disease duration of 20.6 years ± 8.5 at examination [10] [11] [12] . Additional vibration sense disturbances in the lower legs without evidence of peripheral neuropathy, were found in all our patients and were more frequent than the previously reported 23-71 % [5, 10, 11] . The frequency of urinary urgency (7/10) and mild hand ataxia (3/10) was similar or Fig. 1 Pedigree of the large Dutch SPG8 family: Male (square) and female (circles) individuals with spastic paraplegia are indicated with black-filled symbols, multiple healthy siblings are displayed as diamonds with the number of individuals, deceased individuals with striked-out symbols. Clinical information was not available for generations I-IV, but it is expected that the connecting individuals between the two branches of the family have had HSP (?). Deceased individuals that were not neurologically examined were affected according to at least two relatives. G696A/?: heterozygous for the KIAA0196 mutation, ?/? two normal alleles: no mutation in the KIAA0196 gene Fig. 2 KIAA0196 protein alignment. A partial protein alignment (corresponding to residue 680 up to 710 of the human protein, oneletter code) of KIAA0196 orthologs is shown. The alignment was made using ClustalW, and based on the protein sequences of the human (NP_055661.3), chimp (XP_519952.2), macaque (AFE81124.1), dog (XP_532327.2), cat (XP_004000182.1), cow (XP_002692668.1), mouse (NP_705776.2), opossum (XP_001370592.1), chicken (XP_418441.2), frog (NP_001004970.1), zebrafish (NP_956477.1), fruit fly (NP_ 648840.1) and nematode (CCD73362.1) reference sequences. The conserved Gly (position 696 in the human sequence) that is mutated in this family is indicated (box). Residues that differ from the human sequence are marked with a grey background Table 1 Clinical characteristics of 10 affected subjects with the KIAA0196 mutation (patient numbers refer to Fig. 1 ? /?
? /?
Babinski sign ?/?
Walking ability lower than in the other families [10] [11] [12] . Exercise or emotion induced increase of spasticity and gait problems reported by seven individuals, and frequent nonrheumatic joint pains in three of our patients have so far not been described in SPG8 patients. Whether these symptoms are part of a specific SPG8 phenotype is uncertain, as the number of affected patients is small and these specific symptoms have not been systematically investigated in other HSPs. The chronic nonspecific lower back pain in five patients might be (at least partly) coincidental, because of the relative high frequency thereof in general, or could be secondary to the spastic gait as it occurs in other HSP patients as well. Within a small AD-HSP cohort of 21 patients, in whom at least ATL1, SPAST and REEP1 mutations had been excluded, we found two distantly related patients harbouring the novel KIAA0196 mutation. The frequency of *8 % (2/24) reported before in the Canadian ATL1 and SPAST-negative AD-HSP cohort [5] , suggests that SPG8 is almost as frequent as SPG31 caused by REEP1 mutations, the third most frequent AD-HSP up to now [1] . The fact that this is only the fourth mutation in a seventh family reported worldwide, more than 5 years after the first three missense mutations-p.(Asn471Asp) in exon 11, p.(Leu619-Phe) in exon 14 and p.(Val626Phe) in exon 15-were identified [5] , suggests possible underreporting. Conversely, SPG8 may be rarer than anticipated by these two relatively small cohorts.
This report describes the fourth (missense) mutation in the KIAA0196 gene, identified in a large Dutch family with a less severe pure adult-onset spastic paraplegia than previously described, which will add to the current sparse information about this AD-HSP subtype.
